SAJA licensing and manufacturing cooperation with Sanofi
Licensing and manufacturing cooperation with Sanofi
SAJA announced signing a contract in December 2015 with Sanofi to launch the premium anti diabetic drug (Vivaro ®) as a second brand of Sanofi blockbuster (Lantus®).
By signing this agreement both companies shall be allies in fighting diabetes that affects around 20.6% of adults in Saudi Arabia.
The contract reflects the trust in SAJA as trusted partner in the ethical products and the deal shall strengthen the strategy of SAJA to penetrate the anti diabetes market by strong portfolio.